Seminar Presentation in the subject "Inorganic Chemistry" with the title "Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents". With the following contents:
-The problems of the currently used anticancer drugs;
- Palladium derivatives as an alternative to Platinum-based compounds;
- The first Water-Soluble Iminophosphorane Ligand;
- Preparation of Water-Soluble Ligand 1;
- Stability of Compounds in Solution;
- Cytotoxicity IC50 (μM) of Cisplatin, Ligand 1, Phosphine Oxide, TPA=O, and Metal Complexes 2-8 in Human cell lines;
- The Annexin V Binding Assay;
- Activity of Compounds 2 or 3 (50 μM) and Cisplatin against apoptosis-resistent cells;
- Chromosomal DNA and Plasmid DNA;
- Interactions of 2 and 3 with Plasmid DNA Using Electroforesis Mobility Shift Assay (EMSA);
- Interaction with Human Serum Albumin;
- Stern-Volmer plot for quenching with ligand 1 and compounds 2, 3, and 5 – 8 and cisplatin;
- Advantage over Cisplatin;
- Summery
Table of Contents
1. The problems of the currently used anticancer drugs
2. Palladium derivatives as an alternative to Platinum-based compounds
3. The first Water-Soluble Iminophosphorane Ligand
4. Preparation of Water-Soluble Ligand 1
5. Stability of Compounds in Solution
6. Cytotoxicity
7. The Annexin V Binding Assay
8. Activity of Compounds 2 or 3 (50 uM) and Cisplatin against apoptosis-resistent cells
9. Chromosomal DNA and Plasmid DNA
10. Interactions of 2 and 3 with Plasmid DNA Using Electroforesis Mobility Shift Assay (EMSA)
11. Interaction with Human Serum Albumin
12. Stern-Volmer plot for quenching with ligand 1 and compounds 2, 3, and 5 - 8 and cisplatin
13. Advantage over Cisplatin
14. Summery
Research Objectives and Key Topics
This presentation investigates the development and biological evaluation of organometallic palladium complexes utilizing a novel water-soluble iminophosphorane ligand as a potential alternative to conventional platinum-based anticancer agents, focusing on overcoming issues like resistance and high toxicity.
- Overcoming clinical limitations of cisplatin, such as toxicity and drug resistance.
- Synthesis and characterization of water-soluble iminophosphorane-based palladium complexes.
- Evaluation of cytotoxicity in human cell lines and apoptosis induction.
- Interaction studies with plasmid DNA and human serum albumin (HSA).
Excerpt from the Work
The problems of the currently used anticancer drugs
Effectiveness is hindered by clinical Problems like:
Aquired or intrinsic resistance
Limited spectrum of activity
High toxicity leading to side effects
Summary of Chapters
The problems of the currently used anticancer drugs: Outlines the clinical challenges associated with existing platinum-based chemotherapy agents.
Palladium derivatives as an alternative to Platinum-based compounds: Discusses the structural rationale for using palladium complexes and the importance of ligand stabilization.
The first Water-Soluble Iminophosphorane Ligand: Introduces the specific properties of the novel ligand designed for organometallic derivation.
Preparation of Water-Soluble Ligand 1: Describes the synthetic pathway and stability requirements for the ligand.
Stability of Compounds in Solution: Presents the findings on the chemical stability of the synthesized complexes in aqueous and organic media.
Cytotoxicity: Compares the IC50 values of the developed compounds against various human cell lines.
The Annexin V Binding Assay: Explains the method used to detect apoptotic cell death in the study.
Activity of Compounds 2 or 3 (50 uM) and Cisplatin against apoptosis-resistent cells: Highlights the performance of specific complexes in challenging cellular environments.
Chromosomal DNA and Plasmid DNA: Provides background on the DNA structures used for interaction assays.
Interactions of 2 and 3 with Plasmid DNA Using Electroforesis Mobility Shift Assay (EMSA): Details the experimental results of complex-DNA binding affinity.
Interaction with Human Serum Albumin: Analyses the quenching effects and binding interactions with serum proteins.
Stern-Volmer plot for quenching with ligand 1 and compounds 2, 3, and 5 - 8 and cisplatin: Presents quantitative data on the interaction with albumin.
Advantage over Cisplatin: Summarizes the therapeutic benefits of the new compounds over traditional medication.
Summery: Provides a comprehensive overview of the research findings and experimental conclusions.
Key Words
Organometallic Palladium Complexes, Iminophosphorane Ligand, Anticancer Agents, Cisplatin, Cytotoxicity, Apoptosis, Water-soluble, Plasmid DNA, Serum Albumin, Drug Resistance, IC50, Bioinorganic Chemistry, Fluorescence Quenching, Cell Viability, Therapeutic Index
Frequently Asked Questions
What is the primary motivation for this research?
The research aims to address the limitations of current platinum-based drugs like cisplatin, which often suffer from high toxicity, limited spectrum of activity, and the development of clinical drug resistance.
What is the core focus of the study?
The study focuses on the design and testing of organometallic palladium complexes featuring a novel water-soluble iminophosphorane ligand as a safer and more effective alternative for cancer treatment.
What is the central research question?
The central question is whether these novel palladium complexes can maintain high cytotoxic activity against tumor cells—including those resistant to cisplatin—while minimizing side effects and improving solubility.
Which scientific methods were employed?
The work utilizes various analytical techniques including 31P-NMR spectroscopy for stability, cell viability assays (IC50) for cytotoxicity, Annexin V assays for apoptosis, and Electrophoresis Mobility Shift Assays (EMSA) for DNA interaction studies.
What does the main body of the work cover?
The main body covers the synthetic pathway of the ligand, chemical stability analysis in solution, cytotoxicity tests across multiple human cell lines, and mechanistic interaction studies with DNA and serum albumin.
What characterizes these new complexes?
The complexes are characterized by their water solubility, stability in solution, improved capability to induce apoptosis in resistant cell lines, and distinct interaction profiles with biological molecules compared to cisplatin.
How do these compounds behave compared to cisplatin?
The study demonstrates that the palladium complexes show lower cytotoxicity to normal cells and, in some cases, greater efficacy against apoptosis-resistant cell lines compared to cisplatin.
What is the significance of the Annexin V Binding Assay in this research?
It provides a quantitative measure of apoptotic cell death, helping the researchers distinguish between different modes of cell death induced by the test compounds.
How does the interaction with human serum albumin affect the drugs?
The fluorescence quenching studies show that these compounds interact faster with human serum albumin than cisplatin, which is a crucial factor for drug transport and bioavailability in the bloodstream.
What is the main finding regarding DNA interaction?
The research concludes that the interactions of the tested compounds with plasmid DNA are generally much weaker than those observed with cisplatin, suggesting that these compounds may target biological structures through different mechanisms.
- Arbeit zitieren
- Sadik Mejid (Autor:in), 2014, Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents, München, GRIN Verlag, https://www.hausarbeiten.de/document/475220
